1. INTRODUCTION {#sec1}
===============

Titanium-based reagents have significant potential against solid tumors. Budotitane (\[cis-diethoxybis(1-phenylbutane-1,3-dionato)titanium(IV)\]) looked very promising during its preclinical evaluation, but did not go beyond Phase I clinical trials, although a Cremophor EL-based formulation was found for this rapidly hydrolysing molecule \[[@B1]\]. Much more robust in this aspect of hydrolysis is titanocene dichloride (Cp~2~TiCl~2~), which shows medium antiproliferative activity in vitro but promising results in vivo \[[@B2], [@B3]\]. Titanocene dichloride reached clinical trials, but the efficacy of Cp~2~TiCl~2~ in Phase II clinical trials in patients with metastatic renal cell carcinoma \[[@B4]\] or metastatic breast cancer \[[@B5]\] was too low to be pursued.

More recently, novel methods starting from fulvenes \[[@B6]--[@B17]\] and other precursors \[[@B18]--[@B20]\] allow direct access to highly substituted titanocenes via reductive dimerisation, carbolithiation, or hydridolithiation of the fulvene followed by transmetallation in the last two cases.

Titanocene **Y** was obtained using hydridolithiation of fulvene, and it showed an IC~50~ value of 21 *μ*M \[[@B12]\]. The antiproliferative activity of Titanocene has been studied in 36 human tumor cell lines \[[@B21]\] and in explanted human tumors \[[@B22]\]. These in vitro and ex vivo experiments showed that prostate, cervix, and renal cell cancers are prime targets for these novel classes of titanocenes, whereas the IC~50~ values for the breast cancer cell lines were very promising as well. These results were underlined by first mechanistic studies concerning the effect of these titanocenes on apoptosis and the apoptotic pathway in prostate cancer cells \[[@B23]\]. Furthermore, first animal studies have been published recently, reporting the successful treatment of xenografted Ehrlich\'s ascites tumor in mice with an ansa-titanocene \[[@B24]\] and xenografted Caki-1 tumors with Titanocene \[[@B25]\], showing that the effect of Titanocene **Y** against xenografted Caki-1 tumors in mice was superior to cisplatin. The structure of Titanocene **Y** is shown in [Figure 1](#fig1){ref-type="fig"}.

So far, our most cytotoxic titanocene, Titanocene **C** (bis-($N,N$-dimethylamino-2($N$-methylpyrrolyl)methylcyclo pentadienyl) titanium (IV) dichloride, was obtained through carbolithiation of fulvenes, which has been published recently \[[@B26]\]. It has an IC~50~ value of 5.5 *μ*M when tested on the LLC-PK cell line. Its structure is shown in [Figure 1](#fig1){ref-type="fig"}. This meant significant progress, since Cp~2~TiCl~2~ exhibits an IC~50~ value of only 2000 *μ*M against LLC-PK, which explains partly the failed Phase II clinical trials against renal cell carcinoma. The main idea behind the research presented in this paper was to improve the cytotoxicity of Titanocene **C** by adding extra dimethylamino groups using the well-established Mannich reaction. Within this paper, we present a new series of chiral titanocenes, their synthesis, and preliminary cytotoxicity studies.

2. EXPERIMENTAL {#sec2}
===============

2.1. General conditions {#subsec2.1}
-----------------------

Titanium tetrachloride (1.0 M solution in toluene) and butyl lithium (2.0 M solution in pentane) were obtained commercially from Aldrich Chemical Co. (Wis, USA). THF was dried over Na and benzophenone, and it was freshly distilled and collected under an atmosphere of argon prior to use. Manipulations of air and moisture sensitive compounds were done using standard Schlenk techniques under an argon atmosphere. NMR spectra were measured on either a Varian 300 or a 400 MHz spectrometer. Chemical shifts are reported in ppm and are referenced to TMS. IR spectra were recorded on a Perkin Elmer Paragon 1000 FT-IR Spectrometer employing a KBr disk. UV/Vis spectra were recorded on a Unicam UV4 Spectrometer, while CHN analysis was done with an Exeter Analytical CE-440 Elemental Analyser.

2.2. Synthesis {#subsec2.2}
--------------

6-($N,N$-dimethylamino) fulvene **(3)** was synthesised according to the already published procedure \[[@B27]\].

To a Schlenk flask with 2,4\[bis($N,N$-dimethylamino) methyl\]-$N$-methyl pyrrole (1.61 g, 8.25 mmol), 20 ml of THF were added until a transparent solution was formed, while stirring at room temperature. The solution was cooled down to −78°C for 15 minutes and 4.8 mL (8.25 mmol) of butyl lithium were added. The solution was allowed to warm up to 0°C for 20 minutes, resulting in the formation of the yellow lithium intermediate.

In a second Schlenk flask, 6-($N,N$-dimethylamino) fulvene (1.00 g, 8.25 mmol) was dissolved in THF, and the resultant orange solution was added via cannula at −78°C to the Schlenk flask containing the lithiated intermediate. The reaction mixture was then allowed to warm up to room temperature and left stirring for 40 minutes. Titanium tetrachloride (4.1 ml, 4.13 mmol) was added afterwards in situ at room temperature, and the mixture was refluxed for 20 hours. Subsequently, the solvent was removed under vacuum, resulting in the formation of a dark brown oil that was dissolved in dichloromethane and filtered through Celite to remove the LiCl. The black filtrate was filtered additionally twice by gravity filtration. The solvent was removed under reduced pressure forming a shiny dark red solid, which was washed with 20 ml of pentane and then dried in vacuo (1.44 g, 1.93 mmol, 46.8% yield).

^1^H NMR (*δ* ppm CDCl~3~, 400 MHz): 6.36 (m, 8 H, C~5~ [H]{.ul} ~4~); 6.05 (s, 2 H, \[C~4~ [H]{.ul}(CH~2~--N(CH~3~)~2~)~2~N(CH~3~)\]); 3.8--2.6 (m, 14 H, \[C~4~H(CH~2~--N(C[H]{.ul} ~3~)~2~)~2~N(C[H]{.ul} ~3~)\], \[C~4~H(CH~2~--N(CH~3~)~2~)~2~N(C[H]{.ul} ~3~)\], \[C~4~H(C[H]{.ul} ~2~--N(CH~3~)~2~)~2~N(C[H]{.ul} ~3~)\]); 2.36 (s, 26 H, C~4~ [H]{.ul}(CH~2~--N(C[H]{.ul} ~3~)~2~)~2~N(CH~3~)).

^13^C NMR (*δ* ppm CDCl~3~, 125 MHz, proton decoupled): 138, 135, 132, 126, 121, 119, 108 \[[C]{.ul} ~5~H~4~ and [C]{.ul} ~4~H(CH~2~--N(CH~3~)~2~)~2~N(CH~3~)\]; 52 \[C~5~H~4~--[C]{.ul}H--(N(CH~3~)~2~)(C~4~H(CH~2~--N(CH~3~)~2~)~2~N(CH~3~)\]; 34, 32 \[N([C]{.ul}H~3~)~2~ and C~4~H([C]{.ul}H~2~--N([C]{.ul}H~3~)~2~)~2~N([C]{.ul}H~3~)\].

IR absorptions (cm^−1^ KBr): 3414, 2917, 2769, 1620, 1466, 1382, 1018.

Anal. Calc. for C~38~H~62~N~8~TiCl~2~: C, 60.87; H, 8.35; N, 14.95; Cl, 9.46; Found: C, 59.80; H, 8.29; N, 14.18; Cl, 9.45.

UV-Vis (CH~2~Cl~2~): *λ* 244 nm ($ɛ$ 10 833), *λ* 330 nm ($ɛ$ 12 996), $\lambda_{\text{max}}$ 510 nm (weak).

To a Schlenk flask with $N$-($N^{\prime},N^{\prime}$-dimethylaminomethyl) benzimidazol (1.45 g, 8.25 mmol), 20 ml of THF were added until a transparent solution was formed, while stirring at room temperature. The solution was cooled down to −78°C for 15 minutes and 14.0 ml (8.25 mmol, 1.7 M) of butyl lithium were added. The solution was allowed to warm up to 0°C for 20 minutes, resulting in the formation of the yellow lithium intermediate.

In a second Schlenk flask, 1.00 g (8.25 mmol) of 6-$N$,$N$-dimethylamino fulvene was dissolved in THF, and the resultant red solution was added via cannula at −78°C to the Schlenk flask containing the lithiated intermediate. The reaction mixture was then allowed to warm up to room temperature and left stirring for 40 minutes. Titanium tetrachloride (4.1 ml, 4.13 mmol) was added afterwards in situ at room temperature and the mixture was refluxed for 20 h. Subsequently, the solvent was removed under vacuum, resulting in the formation of a dark green oil that was dissolved in dichloromethane and filtered through Celite to remove the LiCl. The black filtrate was filtered additionally twice by gravity filtration. The solvent was removed under reduced pressure forming a shiny black solid, which was washed with 20 ml of pentane and then dried in vacuo (1.97 g, 2.77 mmol, 67.3% yield).

^1^H NMR (*δ* ppm CDCl~3~, 400 MHz): 7.80--7.82 \[m, 4H, C~5~H~4~--CH\[N(CH~3~)~2~\]--C--N--C--C[H]{.ul}--CH--CH--C[H]{.ul}--C--N (CH~2~N(CH~3~)~2~)\]; 7.49--7.51 \[m, 4 H, C~5~H~4~--CH\[N(CH~3~)~2~\]--C--N--C--CH--C[H]{.ul}--C[H]{.ul}--CH--C--N(CH~2~N(CH~3~)~2~\]; 6.42--6.71  \[m, 8H, C~5~ [H]{.ul} ~4~--CH\[N(CH~3~)~2~\]--C~7~H~4~NN--CH~2-~N (CH~3~)~2~\]; 4.85 \[s, 4H, C~5~H~4~--CH\[N(CH~3~)~2~\]--C~7~H~4~NN--C[H]{.ul} ~2-~N (CH~3~)~2~\]; 4.00 \[m, 2H, C~5~H~4~--C[H]{.ul}\[N(CH~3~)~2~\]--C~7~H~5~N~2~--CH~2-~N--(CH~3~)~2~\]; 2.16, 2.23, 2.34 \[s, 24 H, C~5~H~4~--CH  \[N(C[H]{.ul} ~3~)~2~\]--C~7~H~5~N~2~--CH~2-~N--(C[H]{.ul} ~3~)~2~\].

^13^C NMR (*δ* ppm CDCl~3~, 125 MHz, proton decoupled): 144, 142, 136, 135, 132, 126, 123, 122, 121, 120, 119, 112\[[C]{.ul} ~5~H~4~--CH\[N(CH~3~)~2~\]--[C]{.ul} ~7~H~5~N~2~--CH~2-~N--(CH~3~)~2~\]; 69, 68,64,44,43,36,34,32,23,28,19,14,13\[C~5~H~4~--[C]{.ul}H\[N([C]{.ul}H~3~)~2~\]--C~7~H~5~N~2~--[C]{.ul}H~2-~N--([C]{.ul}H~3~)~2~\].

IR absorptions (cm^−1^ KBr): 3429, 2926, 1635, 1456, 1270, 1039, 861, 743.

Anal. Calc. for C~36~H~46~N~8~TiCl~2~: C, 60.93; H, 6.53; N, 15.79; Cl, 9.99 Found: C, 59.99; H, 6.52; N, 15.72; Cl, 9.99.

UV-Vis (CH~2~Cl~2~): *λ* 230 nm ($ɛ$ 22 770), *λ* 402 nm ($ɛ$ 2020), *λ* 499 nm ($ɛ$ 210), $\lambda_{\text{max}}$ 523 nm (weak).

To a Schlenk flask with 0.37 g (1.73 mmol) $p$-($N,N$-dimethylamino)methylphenylbromide, 14 ml of THF were added until a transparent solution was formed, while stirring at room temperature. The solution was cooled down to −78°C and 1.02 ml (1.73 mmol, 1.7 M) of $t$-butyl lithium were added. The solution was allowed to warm up to 0°C for 20 minutes, resulting in the formation of the yellow lithium intermediate.

In a second Schlenk flask, 0.21 g (1.73 mmol) of 6-($N,N$-dimethylamino) fulvene was dissolved in THF, and the resultant red solution was added via cannula at −78°C to the Schlenk flask containing the lithiated intermediate. The reaction mixture was then allowed to warm up to room temperature and left stirring for 40 minutes. Titanium tetrachloride (0.86 ml, 0.86 mmol) was added afterwards in situ at room temperature and the mixture was refluxed for 20 h. Subsequently, the solvent was removed under vacuum, resulting in the formation of a dark brown oil that was dissolved in dichloromethane and filtered through Celite to remove the LiCl. The black filtrate was filtered additionally twice by gravity filtration. The solvent was removed under reduced pressure forming a shiny dark brown solid, which was washed with 150 ml of pentane and then dried in vacuo (0.45 g, 0.71 mmol, 82.7% yield).

^1^H NMR (*δ* ppm CDCl~3~, 300 MHz): 7.73--7.43 \[m, 8H, C~6~ [H]{.ul} ~4~CH~2~N(CH~3~)~2~\]; 6.70--6.40 \[m, 8H, C~5~ [H]{.ul} ~4~\]; 3.14 \[s, 2H, C~5~H~4~--C[H]{.ul}--(N(CH~3~)~2~(C~6~H~4~CH~2~N(CH~3~)~2~)\]; 4.25--4.21 \[s, 4H, C~5~H~4~--CH--(N(CH~3~)~2~(C~6~H~4~C[H]{.ul} ~2~N(CH~3~)~2~)\]; 2.84--2.81 \[s, 12H, C~5~H~4~--CH--(N(C[H]{.ul} ~3~)~2~(C~6~H~4~CH~2~N(CH~3~)~2~)\]; 2.81--2.77 \[s, 12H, C~5~H~4~--CH--(N(CH~3~)~2~(C~6~H~4~CH~2~N(C[H]{.ul} ~3~)~2~)\].

^13^C NMR (*δ* ppm CDCl~3~, 125 MHz, proton decoupled): 146, 138, 136, 132, 131, 129, 127, 124, 120 \[([C]{.ul} ~6~H~4~ CH~2~N(CH~3~)~2~) and ([C]{.ul} ~5~H~4~)\]; 61 \[C~5~H~4~--[C]{.ul}H--(N(CH~3~)~2~ (C~6~H~4~CH~2~N(CH~3~)~2~))\]; 60 \[(C~6~H~4~ [C]{.ul}H~2~N(CH~3~)~2~)\]; 42 \[C~5~H~4~--CH--(N([C]{.ul}H~3~)~2~(C~6~H~4~CH~2~N([C]{.ul}H~3~)~2~))\].

IR absorptions (cm^−1^ KBr): 3444, 3391, 2958, 2670, 2470, 1621, 1467, 1411, 1261, 1164, 1071, 1013, 943, 798.

Anal. Calc. for C~34~H~46~N~4~TiCl~2~: C, 64.90; H, 7.37; N, 8.91; Cl, 11.27 Found: C, 64.88; H, 7.36; N, 8.90; Cl, 11.27.

UV-Vis (CH~2~Cl~2~): *λ* 263 nm (*ɛ* 86 000), *λ* 275 nm (*ɛ* 94 000), *λ* 298 nm (*ɛ* 98 000), *λ* 320 nm (*ɛ* 108 000), *λ* 340 nm (*ɛ* 72 000), *λ* 390 nm (*ɛ* 35 000), $\lambda_{\text{max}}$ 455 nm (weak).

3. RESULTS AND DISCUSSION {#sec3}
=========================

3.1. Synthesis {#subsec3.1}
--------------

6-($N,N$-dimethylamino) fulvene **(3)** was synthesised according to the already published procedure \[[@B27]\], and its structure is shown in [Scheme 1](#sch1){ref-type="fig"}.

The use of aryl lithium in the synthesis of other metallocenes is well known \[[@B28]--[@B30]\], and it has recently been used for the synthesis of chiral titanocene dichlorides \[[@B26]\].

This time, the carbolithiation method led to the synthesis of a new group of titanocenes that contain stereo centres **(5a--c)**.

The first step of the reaction consists of the formation of the functionalised lithium intermediates **(2a--c)** by reacting the corresponding heterocycles **(1a--c)** with *tert*-butyl lithium. Side reactions were avoided by cooling the reaction down to −78°C during the addition of *tert*-butyl lithium, and subsequent warming up to 0°C.

This step was followed by a nucleophilic addition of the lithiated intermediate to the double bond of 6-$N,N$-dimethylamino fulvene at −78°C. Then the reaction mixture was allowed to warm up to 0°C, resulting in the formation of the appropriately substituted lithium cyclopentadienyl intermediates **4a--c**. This reaction occurs with no stereo-selectivity, and the intermediates **4a--c** already contain a stereogenic carbon.

After stirring the reaction mixture for 40 minutes, two molar equivalents of **4a**, **4b** or **4c** underwent a transmetallation reaction when reacted with TiCl~4~ under reflux over 20 h in THF to give titanocenes **5a--c**.

The compounds obtained are shiny dark red solids. The synthesis of these compounds is shown in [Scheme 1](#sch1){ref-type="fig"}.

All three titanocenes shown in this paper have different isomers as seen in [Figure 1](#fig1){ref-type="fig"}. As a result of this, three different signals should be seen for every proton and carbon in the ^1^H and ^13^C NMR spectra. The R,R and S,S isomers are enantiomers and thus give identical NMR spectra, whereas for protons or carbons corresponding to the R,S (same as S,R) isomer, two signals can be observed as the environment of the two cyclopentadienyl rings is different. A relation of 2 : 1 : 1 for S,S and R,R, and the two signals for the S,R (or R,S) isomers can be observed in the integration pattern.

3.2. Cytotoxicity studies {#subsec3.2}
-------------------------

Preliminaryin vitro cell tests were performed on LLC-PK cells in order to compare the cytotoxicity of the compounds presented in this paper. This cell line was chosen based on their long-lasting growth behavior, similar to the one shown in carcinoma cells. It was obtained from the ATCC (american tissue cell culture collection) and maintained in Dulbecco\'s modified Eagle medium containing 10% (v/v) FCS (foetal calf serum), 1% (v/v) penicillin streptomycin, and 1% (v/v) L-glutamine. Cells were seeded in 96-well plates containing 200 *μ*l microtiter wells at a density of 5,000-cells/200 *μ*l of medium and were incubated at 37°C for 24 h to allow for exponential growth. Then the compounds used for the testing were dissolved in the minimal amount of DMSO (dimethylsulfoxide) possible and diluted with medium to obtain stock solutions of $5 \times 10$ ^−4^ M in concentration and less than 0.7% of DMSO. The cells were then treated with varying concentrations of the compounds and incubated for 48 hours at 37°C. Then the solutions were removed from the wells, the cells were washed with PBS (phosphate buffer solution), and fresh medium was added to the wells. Following a recovery period of 24 h incubation at 37°C, individual wells were treated with a 200 *μ*l of a solution of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in medium. The solution consisted of 30 mg of MTT in 30 ml of medium. The cells were incubated for 3 hours at 37°C. The medium was then removed and the purple formazan crystals were dissolved in 200 *μ*L DMSO per well. Absorbance was then measured at 540 nm by a Wallac Victor (Multilabel HTS Counter) Plate Reader. Cell viability was expressed as a percentage of the absorbance recorded for control wells. The values used for the dose response curves of [Figure 2](#fig2){ref-type="fig"} represent the values obtained from four consistent MTT-based assays for each compound tested.

As seen in [Figure 2](#fig2){ref-type="fig"}, Titanocenes **5a--c** showed an IC~50~ value of 23, 52, and 13 *μ*M, respectively.

When compared to unsubstituted titanocene dichloride (IC~50~ value = 2000 *μ*M), titanocene **5c** shows a major decrease in magnitude in terms of the IC~50~ value, and approximately a fourfold increase in magnitude with respect to cisplatin itself (IC~50~ value = 3.3 *μ*M). However, titanocene **5c** shows a decrease in cytotoxicity with respect to Titanocene **C**. The increased polarity of the new titanocenes together with an increase in size might be the cause of the decrease in cytotoxicity shown.

3.3. Structural DFT discussion {#subsec3.3}
------------------------------

Despite our efforts to crystallise these three titanocenes, no crystal structures were obtained. This might be explained by the existence of different isomers in the racemic mixture. In order to overcome this problem, density functional theory (DFT) calculations were carried out for titanocene **5c** at the B3LYP level using the 6-31G\*\* basis set \[[@B31]\], and compared with that of Titanocene **C** \[[@B26]\].

Selected bond lengths of the optimised structure of titanocenes **5a** and **C** are listed in [Table 1](#tab1){ref-type="table"} (for atom numbering, see [Scheme 2](#sch2){ref-type="fig"}). The calculated structure of **5c** is presented in [Figure 3](#fig3){ref-type="fig"}.

The length of the bond between the metal centre and the cyclopentadienyl carbons is slightly different for the different Cp rings (251.3 and 248.5 pm, resp.). The same applies for the carbon-carbon bonds of the cyclopentadienyl rings with bond lengths between 140.2 and 143.4 pm.

The bond length between the methylic carbon centre and the carbon centre of the Cp group is of 152.2 and 152.0 pm, respectively. As well, the length of the bond between the methylic carbon and the nitrogen of the dimethylamino group is almost identical in all cases, and between 152.0 and 148.2 pm, respectively. The steric impediment of the dimethylamino groups attached to the methylic carbons causes a lengthening of the bond, in order to relieve the resultant steric strain.

The Cl$–$Ti$–$Cl angle was calculated to be 95.1°. The angle formed between C~1~ and C~1′~, the respective methylic carbons (C~6~ or C~6*′*~), and C~7~ or C~7*′*,~ respectively, was of 11.42° in both cases, and almost identical to the one formed between each nitrogen of the dimethylamino group, C~6~ or C~6*′*~, and C~1~ and C~1*′*,~ respectively.

The DFT calculated structure of **5a** was then compared to the calculated structure of its mono-$N$-methylpyrrolyl-substituted analogue, Titanocene **C** \[[@B26]\]. In this complex, the length of the bond between the titanium centre and the two Cl atoms appeared to differ in only 1 pm approximately from the one found for **5c**, and of 234.9 and 236.1 pm, respectively. The same applies to the bond length between the N~1~ or N~2~ and C~6~ or C~6*′*,~ respectively, and to the length of the bond between the Cp carbon atoms and the titanium centre.

The Cl$–$Ti$–$Cl angle in Titanocene **C** is very similar to the one calculated for **5c**, and of 94.9°, and so is the angle formed between the titanium centre and the centre of the Cp rings (with a difference of 0.3°).

Selected bond lengths from the calculated DFT structure of Titanocene **C** are listed in [Table 1](#tab1){ref-type="table"}, while atom numbering can be seen in [Scheme 2](#sch2){ref-type="fig"}.

The cartesian coordinates for the DFT optimised structure of titanocene 5C can be observed in the supplementary material, where the energy of optimisation is also found.

4. CONCLUSIONS AND OUTLOOK {#sec4}
==========================

The carbolithiation of 6-($N,N$-dimethylamino) fulvene with Mannich-functionalised lithiated species followed by transmetallation offers a general way into the synthesis of new chiral $N,N$-dimethylamino-functionalised metallocenes. Derivative **5c** exhibits an impressive cytotoxicity with an IC~50~ value of 13 *μ*M against LLC-PK cells, but is slightly less active with respect to Titanocene **C** that shows the highest cytotoxicity for a published titanocene so far.

The authors thank the Higher Education Authority (HEA), the Centre for Synthesis and Chemical Biology (CSCB), UCD, and COST D39 for funding.
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###### 

Selected bond lengths from the DFT-calculated structure of **5c** and DFT-calculated structure of Titanocene **C**.

                    DFT structure **(5c)**   DFT structure Titanocene **C**
  ----------------- ------------------------ --------------------------------
  Ti−C~1~           251.3                    250.4
  Ti−C~2~           242.9                    242.8
  Ti−C~3~           244.2                    240.0
  Ti−C~4~           240.4                    237.4
  Ti−C~5~           243.2                    242.9
  Ti−C~1*′*~        248.5                    247.8
  Ti−C~2*′*~        239.1                    239.0
  Ti−C~3*′*~        234.2                    233.1
  Ti−C~4*′*~        245.6                    243.7
  Ti−C~5*′*~        250.2                    249.3
  C~1~−C~2~         143.4                    143.2
  C~2~−C~3~         141.6                    141.5
  C~3~−C~4~         141.2                    141.3
  C~4~−C~5~         142.3                    142.3
  C~5~−C~1~         141.4                    141.4
  C~1*′*~−C~2*′*~   141.4                    141.4
  C~2*′*~−C~3*′*~   142.2                    142.4
  C~3*′*~−C~4*′*~   142.3                    142.2
  C~4*′*~−C~5*′*~   140.2                    140.2
  C~5*′*~−C~1*′*~   143.0                    143.0
  C~1~−C~6~         152.2                    152.2
  C~1*′*~−C~6*′*~   152.2                    152.0
  C~6~−C~6*′*~      559.5                    559.5
  C~6~−C~7~         151.5                    152.0
  C~6*′*~−C~7*′*~   152.0                    151.5
  C~6~−N~1~         152.0                    148.3
  C~6*′*~−N~2~      149.7                    148.4
  Ti−Cl~1~          240.5                    234.9
  Ti−Cl~2~          234.1                    236.1

[^1]: Recommended by Jannie C. Swarts
